Respiratory Care Devices Market by Product, Monitoring, End-user and Indication - Global Forecast to 2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End-User (Hospital, Home Care), Indication - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The respiratory care devices market is expected to reach USD 29.86 billion by 2025, from USD 16.09 billion in 2019.
Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for respiratory care devices. Thus, the respiratory care devices market witnessed a CAGR of 261.1% between 2019 and 2020. In 2020, the respiratory care devices market reached USD 58.1 billion. The growth of this market is mainly attributed to the high prevalence of respiratory diseases, rising aging population across the globe, high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. However, a lack of awareness-leading to a large underdiagnosed and undertreated population and the harmful effects of specific respiratory care devices on neonates have hampered market growth to an extent.
COPD was the largest and fastest-growing indication of respiratory care devices market in 2019.
COPD is a medical term referring to a group of lung diseases, including chronic bronchitis and emphysema. It is an inflammatory and progressive life-threatening lung disease characterized by a persistent blockage of airflow from the lungs. One of the major causes of COPD is tobacco smoking. According to the US CDC, as many as eight in 10 COPD-related deaths are due to smoking. Additionally, rising indoor (biomass fuel) and outdoor air pollution levels, exposure to dust and chemicals (vapors, irritants, and fumes), genetic disorders, and increasing geriatric population are other factors driving the prevalence of COPD. The elements, as mentioned above, are expected to drive the demand for respiratory care devices during the forecast period.
Hospitals are the largest end-user segment in the respiratory care devices market in 2019
Based on end-user, the respiratory care devices market is divided into hospitals, home care settings, and ambulatory care. Hospitals form the largest end-user segment of the respiratory care devices market. This can largely be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Hospitals provide respiratory care services to patients through various departments, such as intensive care units, emergency rooms, outpatient departments, and pulmonary diagnostic laboratories, among others. Moreover, COVID-19 has tremendously impacted o the hospital segment. Several hospitals have been established in order to cure an increasing number of patients infected from the coronavirus.
North America will continue to dominate the respiratory care devices market in 2025
The respiratory care devices market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the respiratory care devices market. The large share of North America in this market can be attributed to the outbreak of COVID-19, which has driven the demand for respiratory devices in North America. Due to its growing geriatric population segment and environmental conditions that have favored the spread of the disease, COVID-19 has severely affected the region and ensured enormous growth in the demand for respiratory care devices. Players in this and adjacent, or even non-related, markets have focused on or collaborated for expanding the manufacturing of critical care instruments and respiratory care devices.
Market Dynamics
Drivers
- Rising Prevalence of Respiratory Diseases
- Increasing Incidence Rate of Preterm Births
- Outbreak of Infectious Diseases Affecting Respiratory System
Restraints
- Unfavorable Reimbursement Scenario
- Availability of Low-Cost Products From Local Manufacturers
Opportunities
- Growing Demand for Home Care therapeutic Devices
- High Growth in Developing Countries Across APAC and Latin America
- Point-of-Care Diagnostics - an Upcoming Opportunity
Challenges
- Low Awareness and Large Underdiagnosed and Undertreated Population
- Harmful Effects of Certain Devices on Neonates
Companies Profiled
- Philips Healthcare
- Resmed, Inc.
- Medtronic Plc
- Masimo Corporation
- Fisher and Paykel Healthcare Co., Ltd.
- Getinge Ab
- Air Liquide
- Drgerwerk Ag & Co. Kgaa
- Hamilton Medical Ag
- Invacare Corporation
- Vyaire Medical
- Nihon Kohedon Corporation.
- General Electric.
- Apex Medical Corporation.
- Teleflex Incorporated.
- Nonin.
- Allied Healthcare Products, Inc.
- Smiths Medical, Inc.
- Drive Devilbiss Healthcare.
- Omron Healthcare, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/xyqnlt
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
